```html

Arteriovenous Malformation (AVM)

Overview

Arteriovenous malformation (AVM) is an abnormal tangle of blood vessels that directly connects arteries to veins, bypassing the normal capillary network. This shortcut can cause blood to flow at high pressure, leading to vessel rupture, bleeding, or interference with normal organ function.

Who it affects: AVMs can occur anywhere in the body, but the most common locations are the brain (cerebral AVM) and the spine. They are usually present at birth (congenital) but may not cause symptoms until adolescence or adulthood.

Prevalence:

• Overall, AVMs affect roughly 1 in 100,000 people worldwide.
• Cerebral AVMs represent about 0.01%–0.05% of the population, accounting for 2% of all strokes and 10%–15% of hemorrhagic strokes in young adults.
• Spinal AVMs are rarer, occurring in ~1 per 1 million individuals.

(References: Mayo Clinic, CDC, National Institute of Neurological Disorders and Stroke – NINDS)

Symptoms

Symptoms vary based on the AVM’s size, location, and whether it is bleeding. Below is a comprehensive list:

Neurological (brain or spinal AVM)

• Headache: Often sudden and severe if bleeding occurs.
• Seizures: Focal or generalized; may be the first sign in people under 30.
• Focal neurological deficits: Weakness, numbness, or loss of coordination affecting one side of the body.
• Vision changes: Double vision, loss of peripheral vision, or sudden visual field deficits.
• Speech or language problems: Slurred speech, difficulty finding words.
• Balance or gait disturbances: Unsteady walking, frequent falls.
• Spinal cord compression symptoms (for spinal AVM): Back pain, limb weakness, urinary or bowel dysfunction.

General systemic signs

• Audible bruit: A whooshing sound heard over the affected area with a stethoscope.
• Visible skin changes: Warmth, redness, or a pulsatile mass on the skin (often in peripheral AVMs).
• Pain or tenderness: Due to increased blood flow or tissue ischemia.

Bleeding presentation

• Sudden severe headache (“thunderclap” headache).
• Loss of consciousness or sudden decline in mental status.
• Vomiting, especially if blood‑tinged.
• Focal neurological loss that progresses rapidly.

Causes and Risk Factors

Most AVMs are congenital, arising from errors in fetal blood‑vessel development. The exact genetic cause is often unknown, but several mechanisms have been identified.

Genetic and developmental factors

• Hereditary syndromes:
  • Hereditary hemorrhagic telangiectasia (HHT) – Osler‑Weber‑Rendu disease (mutations in ENG, ACVRL1, SMAD4) increases risk of AVMs in brain, lungs, liver, and spine.
  • Capillary malformation‑arteriovenous malformation (CM‑AVM) syndrome (RASGRF2, EPHB4 mutations).
• Somatic mutations: Recent studies suggest that post‑zygotic mutations in angiogenesis pathways (e.g., KRAS, BRAF) may lead to isolated AVMs.

Non‑genetic risk factors

• Age: Many AVMs become symptomatic between ages 20–40.
• Sex: Slight male predominance for cerebral AVMs (≈55% male).
• Radiation exposure: Prior cranial irradiation (for childhood cancers) can induce de novo AVMs.
• Trauma: Rarely, head or spinal injury can precipitate bleeding from a pre‑existing AVM.

Diagnosis

Because symptoms can mimic other conditions (migraine, tumor, stroke), imaging is essential.

Initial assessment

• Detailed neurological exam.
• History focusing on sudden onset, family history of HHT, prior radiation.

Imaging studies

1. Magnetic Resonance Imaging (MRI) with MR‑angiography (MRA): First‑line for suspected cerebral AVM; shows nidus, feeding arteries, draining veins.
2. Computed Tomography (CT) scan & CT‑angiography (CTA): Quickly identifies acute hemorrhage and delineates vessel anatomy.
3. Digital Subtraction Angiography (DSA): Gold standard; provides high‑resolution view of the vascular nidus and is often performed before endovascular treatment.
4. Transcranial Doppler (TCD) or carotid duplex: Useful for peripheral AVMs to assess flow.
5. Spinal MRI/MRA: For suspected spinal AVM, evaluates the cord and surrounding vessels.

Laboratory tests

• Complete blood count (CBC) & coagulation profile if bleeding is suspected.
• Genetic testing for HHT (ENG, ACVRL1, SMAD4) when familial AVMs are suspected.

Treatment Options

Management is individualized based on AVM size, location, symptoms, and patient preferences. The goals are to prevent hemorrhage, control seizures, and preserve neurological function.

Observation (conservative management)

• Small, asymptomatic AVMs may be monitored with periodic MRI/MRA (every 1–2 years).
• Lifestyle counseling (avoid high‑impact sports, control hypertension).

Endovascular embolization

• Catheter‑based delivery of liquid embolic agents (e.g., Onyx, N‑BCA) to block feeding arteries.
• Often used as a pre‑operative adjunct or for AVMs not amenable to surgery.
• Complication risk: vessel perforation, stroke (≈2%–5%).

Microsurgical resection

• Open craniotomy to excise the nidus.
• Best for low‑grade AVMs in non‑eloquent brain regions.
• Complete removal offers the highest cure rate (>90% when feasible).

Stereotactic radiosurgery (SRS)

• Focused radiation (Gamma Knife, CyberKnife) induces gradual vessel thrombosis over 2–3 years.
• Ideal for deep or eloquent‑area AVMs where surgery is high risk.
• Obliteration rates: 60%–80% after 3 years; small risk of radiation‑induced necrosis.

Medical management

• Seizure control: Antiepileptic drugs (levetiracetam, valproate) as per standard guidelines.
• Blood pressure control: Strict hypertension management (target <130/80 mmHg) lowers rupture risk.
• Pain management: NSAIDs or acetaminophen; avoid anticoagulants unless specifically indicated.

Lifestyle and supportive care

• Smoking cessation – smoking doubles the risk of intracerebral hemorrhage.
• Avoid heavy weight‑lifting or contact sports that raise intracranial pressure.
• Regular follow‑up with a neurovascular specialist.

Living with Arteriovenous Malformation

Even after treatment, long‑term care is essential.

• Follow‑up imaging: MRI/MRA at 6 months, then annually for the first 5 years, then per physician recommendation.
• Medication adherence: Take antiepileptics or antihypertensives exactly as prescribed.
• Neuro‑rehabilitation: Physical, occupational, or speech therapy if deficits persist after a bleed or surgery.
• Psychosocial support: Counseling or support groups for anxiety, depression, or coping with chronic disease.
• Insurance & disability planning: Keep records of diagnosis and treatment; some patients may qualify for disability benefits if neurological function is impaired.

Prevention

Since most AVMs are congenital, true primary prevention isn’t possible, but secondary prevention can reduce the risk of complications.

• Control blood pressure aggressively (<130/80 mmHg). CDC
• Quit smoking; seek cessation programs.
• Avoid illicit stimulant use (cocaine, methamphetamine) that spikes blood pressure.
• Wear protective headgear during high‑risk activities (e.g., cycling, contact sports).
• For individuals with HHT or known familial AVMs, undergo regular screening (MRI/MRA) per genetic counseling recommendations.

Complications

If left untreated or after an adverse event, AVMs can lead to serious outcomes.

• Intracranial hemorrhage: Most feared complication; mortality 10%–30% per bleed, with up to 50% of survivors experiencing permanent disability.
• Seizure disorders: May become refractory to medication.
• Neurological deficits: Persistent weakness, speech impairment, visual loss.
• Hydrocephalus: Resulting from blood obstructing cerebrospinal fluid pathways.
• High‑output cardiac failure: Large peripheral AVMs can shunt enough blood to overload the heart.
• Radiation‑induced neoplasia: Rare long‑term risk after stereotactic radiosurgery.

When to Seek Emergency Care

---

Sources: Mayo Clinic. “Arteriovenous malformation (AVM).” mayoclinic.org; CDC. “High Blood Pressure.” cdc.gov; National Institute of Neurological Disorders and Stroke. “Brain AVM Fact Sheet.” nih.gov; World Health Organization. “Haemorrhagic stroke.” who.int; Cleveland Clinic. “Arteriovenous Malformation (AVM) Treatment Options.” clevelandclinic.org.

```